As businesses stay private longer and capital needs evolve, private markets are becoming an increasingly important avenue for value creation.
The opportunity is no longer just about diversification. It’s about access.
#KotakAlts#PrivateMarkets#AlternativeInvestments
We’ve been alerted to individuals impersonating Kotak Alts on WhatsApp and other social platforms, falsely promising high returns & sharing unverified apps
Kotak Alts does not operate any WhatsApp/Telegram investment groups or guarantee returns.
Report activity: [email protected]
As preventive care becomes a core part of healthcare delivery, diagnostics is emerging as a compelling long-term growth opportunity.
Ashish Ranjan, Director, Kotak Alts, shares his perspective on the structural trends shaping this evolution.
#KotakAlts
Alternative Investment Funds offer exposure to investment themes and assets beyond traditional market participation, bringing diversification, selectivity, and a long-term orientation to portfolio construction.
#AlternativeInvestments#PortfolioDiversification#KotakAlts
Kotak Alts invested ₹750 crore in Lloyds Metals, backed by conviction in India’s manufacturing future, regional transformation, and enduring partnerships.
Watch the full conversation: https://t.co/Q3Kxx57q7L
Insights from Kotak Alts’ investments across the Life Sciences and Biotech Ecosystem highlight a broader structural theme, as healthcare demand expands beyond metropolitan centres, infrastructure is becoming an increasingly important enabler of access and delivery.
#KotakAlts
Performance builds trust. Trust attracts capital. Capital creates opportunity.
At Kotak Alts, these principles have enabled us to build enduring partnerships with global investors and deploy capital toward opportunities that shape India’s next phase of economic growth
#KotakAlts
India’s biotech story is evolving. From manufacturing scale to discovery-led innovation, the sector is showing early signs of a new growth cycle, supported by a growing startup ecosystem, rising R&D intensity, and increasing focus on intellectual property creation.
#KotakAlts
Policy stability, with a cautious eye on risks. The RBI kept rates unchanged at 5.25%, while revising inflation higher and growth lower amid rising global and domestic uncertainties.
Our key takeaways from the June 2026 MPC.
#RBIMPC#IndiaEconomy#MonetaryPolicy#KotakAlts
Kotak Alts has achieved the final close of its 14th Real Estate Fund at approximately USD 1 Billion, anchored by ADIA’s sixth consecutive commitment to the platform and supported by NPS Korea’s first-ever investment in Indian alternatives.
Read more: https://t.co/wpIHNGMbqW
Kotak Alts’ ₹360 crore investment in Vishwa Samudra Group’s NHAI road projects reflects the growing role of structured credit in supporting high-quality infrastructure assets with strong execution visibility and predictable cash flows.
Read more:
https://t.co/pAFqs94OlM
Indian Pharma’s next growth curve will likely be defined less by volume and more by the depth of innovation.
As the sector moves up the value chain, differentiated capabilities, specialty platforms, and IP-led businesses could drive the next phase of value creation.
#KotakAlts
Eshwar Karra, Deputy Managing Director, Kotak Alts, shares his perspective on the RBI’s move to allow banks to finance strategic acquisitions, and how it could reshape the private credit market landscape.
Read more: https://t.co/yyEOQd466k
#PrivateCredit#AcquisitionFinancing
At the IVCA Conclave 2026, Srini Sriniwasan, Managing Director, Kotak Alts, & Chairperson, IVCA, underscored a defining reality for India’s alternative investment ecosystem.
Watch the full video: https://t.co/4zkSrGzYax
#KotakAlts#IVCA#AlternativeInvestments#PrivateMarkets
At Kotak Alts, we believe the future of healthcare will be shaped not just by breakthrough science, but by breakthroughs in access. Our investment in @CellogenTher reflects that conviction.
Read the full article by Ashish Ranjan, Director, Kotak Alts: https://t.co/N4fWENLKTQ
As market volatility rises & IPO windows narrow, private credit is emerging as a critical source of flexible capital.
Rahul Chhaparwal, Partner at Kotak Alts, shares why India’s private credit market is seeing a significant influx of capital.
Read more: https://t.co/4mgCAoXeMo
Watch Srini Sriniwasan, Managing Director, Kotak Alts, in conversation with Sashi Krishnan, Director, NISM, at the NISM Masterclass on “India Needs Capital to Finance Innovation and Infrastructure.”
Full Video: https://t.co/NwSgOrD1Yx
Srini Sriniwasan, Managing Director, Kotak Alts, and Chairperson, @IndianVCA, recently met with the Hon’ble Finance Minister of India, Smt. @nsitharamanoffc to discuss the evolving role of alternate capital in supporting India’s economic growth
Read: https://t.co/yPXbeFOrFH
Eshwar Karra, Deputy Managing Director, Kotak Alts, shares his perspective on how geopolitical volatility, delayed IPO activity, and evolving capital requirements are accelerating the shift towards private credit in India.
Read more: https://t.co/zfHCTTCSCi
India’s biotechnology ecosystem is entering a pivotal phase of innovation-led growth. Kotak Alts, through Kotak Life Sciences Fund I, has invested ₹200 Mn in @cellogenindia to advance next-generation cell and gene therapies.
Read more: https://t.co/5NabI2hdoF